Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 4/20 | 0.53 |
| ▸ | JAK3 | P52333 | 4/20 | 0.53 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.53 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.53 |
| ▸ | NTRK1 | P04629 | 9/20 | 0.48 |
| ▸ | GRK6 | P43250 | 7/20 | 0.43 |
| ▸ | AURKA | O14965 | 2/20 | 0.43 |
| ▸ | MUSK | O15146 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | RET | P07949 | 1/20 | 0.40 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.40 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.40 |
| ▸ | FLT3 | P36888 | 1/20 | 0.40 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2565727 | 1.00 | JAK2 (0.53) | JAK2JAK3LIMK1LIMK2NTRK1 | |
| SCHEMBL2561629 | 0.89 | JAK2 (0.42) | JAK2JAK3LIMK1LIMK2NTRK1 | |
| SCHEMBL2561614 | 0.89 | JAK2 (0.42) | JAK2JAK3LIMK1LIMK2NTRK1 | |
| SCHEMBL2578945 | 0.86 | JAK2 (0.51) | JAK2JAK3LIMK1LIMK2NTRK1 | |
| SCHEMBL2567182 | 0.86 | NTRK1 (0.57) | JAK2JAK3LIMK1LIMK2NTRK1 | |
| SCHEMBL2578947 | 0.86 | JAK2 (0.51) | JAK2JAK3LIMK1LIMK2NTRK1 | |
| SCHEMBL2567176 | 0.86 | NTRK1 (0.57) | JAK2JAK3LIMK1LIMK2NTRK1 | |
| SCHEMBL2486709 | 0.84 | JAK3 (0.75) | JAK2JAK3LIMK1LIMK2NTRK1 | |
| SCHEMBL2486710 | 0.84 | JAK3 (0.75) | JAK2JAK3LIMK1LIMK2NTRK1 | |
| SCHEMBL2577239 | 0.83 | JAK2 (0.52) | JAK2JAK3LIMK1LIMK2NTRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2383268-A1 | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | AstraZeneca AB (SE) | 2011-11-02 | — | — | EP | disclosed |